The long-term outcome of kidney transplantation in patients under cyclosporine - A developing country experience

Clinical Transplantation

Volumn 18, Issue 3, 2004, Pages 267-273

  Moosa, M Rafique ^a,b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b NONE   (South Korea)

Author keywords

Conventional treatment; Cyclosporine; Developing countries; Kidney transplantation; Survival

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEVELOPING COUNTRY; FEMALE; GRAFT SURVIVAL; HUMAN; KAPLAN MEIER METHOD; KIDNEY ALLOGRAFT REJECTION; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; COHORT STUDIES; CYCLOSPORINE; DEVELOPING COUNTRIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; SOUTH AFRICA; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 2942521773     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2004.00159.x     Document Type: Article

References (45)

1. Moosa MR, Walele AA, Daar AS. Renal transplantation in developing countries. In: Morris PB ed. Kidney Transplantation: Principles and Practice. Philadelphia, PA: W.B. Saunders, 2001: 659.
2. Myburgh JA, Botha JR, Meyers AM et al. The treatment of end-stage renal disease at the Johannesburg Hospital: a 17-year experience. Part II. The role of transplantation. S Aft Med J 1983: 64: 522.
3. Bauling PC, Steyn E, Venter L, Van Wyk JA. Renal transplant experience in black African patients, with special reference to early survival rates, donor availability and cytomegalovirus. Transplant Proc 1989: 21: 2008.
4. Myburgh JA, Shapiro M, Maier G, Meyers AM. HL-A and cadaver kidney transplantation. 7-year experience at Johannesburg General Hospital. S Afr Med J 1976: 50: 1279.
5. SADTR Report 1994. Combined report on maintenance dialysis and transplantation in the Republic of South Africa. In: du Toit ED, Pascoe M, MacGregor K, Thompson PD eds. Cape Town: SADTR, 1994.
6. Merion RM, White DJ, Thiru S, Evans DB, Calne RY. Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med 1984: 310: 148.
7. Beveridge T, Calne RY. Cyclosporine (Sandimmun) in cadaveric renal transplantation. Ten-year follow-up of a multicenter trial. European Multicentre Trial Group. Transplantation 1995: 59: 1568.
8. Calne RY, Alexandre GP, Murray JE. A study of the effects of drugs in prolonged survival of homologous renal transplantation in dogs. Ann N Y Acad Sci 1962: 99: 743.
9. Cecka M. Clinical outcome of renal transplantation. Factors influencing patient and graft survival. Surg Clin North Am 1998: 78: 133.
10. Arend SM, Mallant MJ, Westendorp RJ, van der Woude FJ, van Es LA. Patient survival after renal transplantation; more than 25 years follow-up. Nephrol Dial Transplant 1997: 12: 1672.
11. Kahan BD. Cyclosporine. N Engl J Med 1989: 321: 1725.
12. Hricik D, Mayes J, Schulak J. Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia. Am J Kidney Dis 1991: 18: 353.
13. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996: 7: 158.
14. Thiel G, Bock A, Spondlin M et al. Long-term benefits and risks of cyclosporin A (Sandimmun) - an analysis at 10 years. Transplant Proc 1994: 26: 2493.
15. Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993: 44: 411.
16. Hirata M, Cho YW, Cecka JM, Terasaki PI. Patient death after renal transplantation-an analysis of its role in graft outcome. Transplantation 1996: 61: 1479.
17. Vincenti F, Amend W, Feduska NJ, Duca RM, Salvatierra O Jr. Improved outcome following renal transplantation with reduction in the immunosuppression therapy for rejection episodes. Am J Med 1980: 69: 107.
18. Tilney NL, Strom TB, Vineyard GC, Merrill JP. Factors contributing to the declining mortality rate in renal transplantation. N Engl J Med 1978: 299: 1321.
19. Standards Committee of the American Society of Transplant Surgeons. Current results and expectations of renal transplantation. JAMA 1981: 246: 1330.
20. Disney AP, Correll RL. Report of the Australian and New Zealand combined dialysis and transplant registry. Med J Aust 1981: 1: 117.
21. Najarian JS, Fryd DS, Strand M et al. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Ann Surg 1985: 201: 142.
22. Calne RY, Wood AJ. Cyclosporin in cadaveric renal transplantation. 3-year follow-up of a European multicentre trial. Lancet 1985: 2: 549.
23. The Canadian Multicenter Transplant Study Group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N Engl J Med 1983: 309: 809.
24. Ponticelli C, Civati G, Tarantino A et al. Randomized study with cyclosporine in kidney transplantation: 10-year follow-up. J Am Soc Nephrol 1996: 7: 792.
25. Marcén R, Pascual J, Teruel JL et al. Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss? Transplantation 2001: 72: 57.
26. Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JM. Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. Kidney Int 1996: 50: 1089.
27. Chapman JR, Marcén R, Arias M, Raine AE, Dunnill MS, Morris PJ. Hypertension after renal transplantation. A comparison of cyclosporine and conventional immunosuppression. Transplantation 1987: 43: 860.
28. Vianello A, Mastrosimone S, Calconi G, Gatti PL, Calzavara P, Maresca MC. The role of hypertension as a damaging factor for kidney grafts under cyclosporine therapy. Am J Kidney Dis 1993: 21: 79.
29. Ponticelli C, Montagnino G, Aroldi A, Angelini C, Braga M, Tarantino A. Hypertension after renal transplantation. Am J Kidney Dis 1993: 21: 73.
30. Hill MN, Grossman RA, Feldman HI, Hurwitz S, Dafoe DC. Changes in causes of death after renal transplantation, 1966 to 1987. Am J Kidney Dis 1991: 17: 512.
31. Kirkman RL, Strom TB, Weir MR, Tilney NL. Late mortality and morbidity in recipients of long-term renal allografts. Transplantation 1982: 34: 347.
32. Najarian JS, Sutherland DE, Simmons RL et al. Ten year experience with renal transplantation in juvenile onset diabetics. Ann Surg 1979: 190: 487.
33. Salvatierra O Jr, Potter D, Cochrum KC et al. Improved patient survival in renal transplantation. Surgery 1976: 79: 166.
34. Washer GF, Schroter GP, Starzl TE, Weil R. Causes of death after kidney transplantation. JAMA 1983: 250: 49.
35. Dlugosz BA, Bretan PN, Novick AC et al. Causes of death in kidney transplant recipients: 1970 to present. Transplant Proc 1989: 21: 2168.
36. Hiesse C, Rieu P, Larue JR et al. Late graft failure and death in renal transplant recipients: analysis in a single-center population of 1500 patients. Transplant Proc 1997: 29: 240.
37. Matas AJ, Gillingham KJ, Sutherland DE. Half-life and risk factors for kidney transplant outcome-importance of death with function. Transplantation 1993: 55: 757.
38. Lindholm A, Albrechtsen D, Frodin L, Tufveson G, Persson NH, Lundgren G. Ischemic heart disease-major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 1995: 60: 451.
39. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000: 57: 307.
40. Herselman M, Moosa MR, Kotze TJ, Kritzinger M, Wuister S, Mostert D. Protein-energy malnutrition as a risk factor for increased morbidity in long-term hemodialysis patients. J Ren Nutr 2000: 10: 7.
41. Almond PS, Gillingham KJ, Sibley R et al. Renal transplant function after ten years of cyclosporine. Transplantation 1992: 53: 316.
42. Scheweitzer EJ, Matas AJ, Gillingham KJ et al. Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s. Ann Surg 1991: 214: 679.
43. Kramer P, Broyer M, Brunner FP et al. Combined report on regular dialysis and transplantation in Europe, XIV, 1983. Proc Eur Dial Transplant Assoc Eur Ren Assoc 1985: 21: 2.
44. Opelz G. Factors influencing kidney graft survival in Latin America. Collaborative Transplant Study. Transplant Proc 1999: 31: 2951.
45. Young CJ, Gaston RS. Renal transplantation in Black Americans. N Engl J Med 2000: 343: 1545.